Solely-Owned Technology. Anything contained in this Agreement to the contrary notwithstanding, as between the Parties (i) ImmunoGen shall be the sole owner of the Licensed Intellectual Property (other than the Joint Program Technology and Joint Improvements included therein), and (ii) Novartis shall be the sole owner of Novartis Improvements and any Patent Rights claiming Novartis Improvements.
Appears in 4 contracts
Samples: Multi Target Agreement (Immunogen Inc), Multi Target Agreement (Immunogen Inc), Multi Target Agreement (Immunogen Inc)
